Sign In
Buy BMRN
$60.02
-0.560 (-0.92%)
At Close: Jul 31, 2026
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean-Jacques Bienaimé on Q1 2020 Results - Earnings Call Transcript
01:06am, Thursday, 30'th Apr 2020
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean-Jacques Bienaimé on Q1 2020 Results - Earnings Call Transcript
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings and Revenue Estimates
05:45pm, Wednesday, 29'th Apr 2020
BioMarin (BMRN) delivered earnings and revenue surprises of 90.91% and 6.73%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
CFRA Analysts Highlight 6 Health Sector Buys For Your Portfolio
01:31pm, Wednesday, 29'th Apr 2020
In spite of Covid-19 and global recession concerns, we have a positive outlook on the biotechnology sub-industry; we expect to see a ramp-up in new drug sales; the continued development of many new, i
Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings
07:15am, Monday, 27'th Apr 2020
In what has become truly the most challenging investing environment in decades, it is probably no surprise to most investors that health care is the top-performing sector this year in the S&P 500.
Biomarin Could Possibly Be The First To Obtain FDA Approval For Hemophilia Gene Therapy Treatment
07:59am, Wednesday, 15'th Apr 2020
Biomarin Could Possibly Be The First To Obtain FDA Approval For Hemophilia Gene Therapy Treatment
Is BioMarin Pharmaceuticals Stock a Buy?
07:36am, Wednesday, 08'th Apr 2020
Is this a prime opportunity for investors to buy the gene therapy drugmaker?
Vertex Pharmaceuticals And BioMarin Pharmaceutical: 2 Safe Biotech Picks To Buy During This Bear Market
02:35pm, Tuesday, 07'th Apr 2020
Vertex Pharmaceuticals And BioMarin Pharmaceutical: 2 Safe Biotech Picks To Buy During This Bear Market
Biomarin to File Regulatory Applications for Vosoritide in Q3
11:04am, Tuesday, 07'th Apr 2020
BioMarin (BMRN) plans to file regulatory applications seeking approval for its achondroplasia candidate, vosoritide, in the third quarter of 2020.
BioMarin (BMRN) Down 8% Since Last Earnings Report: Can It Rebound?
11:30am, Friday, 27'th Mar 2020
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock?
Why BioMarin Pharmaceutical, Bristol-Myers Squibb, and bluebird bio Are Getting Hammered Monday
01:41pm, Monday, 16'th Mar 2020
These biopharma stocks are taking a big hit because of the COVID-19 pandemic.
Why These Drug Stocks Soared Today
05:38pm, Friday, 13'th Mar 2020
An overall market rebound and a presidential press conference carried several biotech and pharmaceutical stocks markedly higher.
Why BioMarin Pharmaceutical Inc. Stock Is Fading Today
11:47am, Thursday, 12'th Mar 2020
BioMarin's stock isn't escaping the marketwide sell-off. Savvy investors, though, may want to take advantage of this latest decline in the drugmaker's shares.
Here's Why Emergent Biosolutions, BioMarin, and Nuvasive Fell on Monday
09:36pm, Monday, 09'th Mar 2020
Even healthcare companies can't escape the overall market downturn.
5 Biotech Stocks to Buy for a Strong Growth Prognosis
06:10am, Friday, 06'th Mar 2020
The long-term outlook is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.
BioMarin (BMRN) Q4 Earnings Beat, Sales Miss, Valrox in Focus
10:38am, Thursday, 27'th Feb 2020
BioMarin (BMRN) announces mixed results for the fourth quarter of 2019, beating estimates for earnings while missing the same for sales.
